Novel Topical Formulations for Hyperpigmentation: Recent Advances and Therapeutic Perspectives

Hyperpigmentation is a common skin disorder in which melanin is overproduced and accumulated leading to development of dark spots on the skin. It can be caused due to various reasons like exposure to uv rays, changes in hormonal levels-inflammatory conditions, genetic factors and skin damage. Various topical drugs like hydroquinone, kojic acid, arbutin, azelaic acid, glycolic acid, niacinamide and vitamin-C have been widely employed in the treatment of hyperpigmentation. However, they suffer from several disadvantages including low solubility, instability, low permeability and causes adverse effects like irritation and allergy. Various advancements have been made in the field of topical drug delivery systems that focus on providing stability, controlled release and permeability of the active drug. Emulgel formulation is gaining popularity as a topical formulation as it combines the advantages of both emulsions and gels, thus improving drug loading, easy spreading properties, stability and patient compliance. Advanced drug delivery systems like liposomes, nanoemulsions, niosomes, solid lipid nanoparticles and nanostructured lipid carriers have shown potential to overcome the shortcomings of conventional drug delivery systems. The present review describes the mechanism of melanogenesis, widely used depigmenting agents and its various drawbacks. Various formulations, permeation enhancers and recent advancement in topical drug delivery have been discussed in this review. Limitations and future perspectives for stable, effective and patient friendly topical formulations for the treatment of hyperpigmentation.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-04
DOI
https://doi.org/10.5281/zenodo.23938825
Primary Topic
Advancements in Transdermal Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Novel Topical Formulations for Hyperpigmentation: Recent Advances and Therapeutic Perspectives

Anushka More, Christina Viju, shrutika patil, Shreeya Shelar et al.
Zenodo (CERN European Organization for Nuclear Research)
Advancements in Transdermal Drug Delivery
article

Novel Topical Formulations for Hyperpigmentation: Recent Advances and Therapeutic Perspectives

Anushka More, Christina Viju, shrutika patil, Shreeya Shelar, Nadim Khan, Saniya Nadhavale
article en

Abstract

Hyperpigmentation is a common skin disorder in which melanin is overproduced and accumulated leading to development of dark spots on the skin. It can be caused due to various reasons like exposure to uv rays, changes in hormonal levels-inflammatory conditions, genetic factors and skin damage. Various topical drugs like hydroquinone, kojic acid, arbutin, azelaic acid, glycolic acid, niacinamide and vitamin-C have been widely employed in the treatment of hyperpigmentation. However, they suffer from several disadvantages including low solubility, instability, low permeability and causes adverse effects like irritation and allergy. Various advancements have been made in the field of topical drug delivery systems that focus on providing stability, controlled release and permeability of the active drug. Emulgel formulation is gaining popularity as a topical formulation as it combines the advantages of both emulsions and gels, thus improving drug loading, easy spreading properties, stability and patient compliance. Advanced drug delivery systems like liposomes, nanoemulsions, niosomes, solid lipid nanoparticles and nanostructured lipid carriers have shown potential to overcome the shortcomings of conventional drug delivery systems. The present review describes the mechanism of melanogenesis, widely used depigmenting agents and its various drawbacks. Various formulations, permeation enhancers and recent advancement in topical drug delivery have been discussed in this review. Limitations and future perspectives for stable, effective and patient friendly topical formulations for the treatment of hyperpigmentation.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 17%
Advancements in Transdermal Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon